Introduction: Prior to 2006, nearly every US child was infected with rotavirus by 5 years of
age, and rotavirus was the leading cause of severe childhood gastroenteritis. In February …

Background Cases of rotavirus-associated acute gastroenteritis have declined since the
introduction of rotavirus vaccines, but the burden of norovirus-associated acute …

Introduction: Acute diarrhea remains a major problem in children and is associated with
substantial morbidity, mortality and costs. While vaccination against rotavirus could reduce …

Background: A substantial number of surveillance studies have documented rotavirus
prevalence among children admitted for dehydrating diarrhea. We sought to establish global …

OBJECTIVE: A publicly funded, universal infant pentavalent rotavirus vaccine (RV5)
program was implemented in Queensland, Australia, in mid-2007. We sought to assess …

Rotaviruses are the most common cause of severe gastroenteritis in children. By 5 years of
age virtually every child worldwide will have experienced at least one rotavirus infection …

The pentavalent rotavirus (RV) vaccine RotaTeq™ has been available in industrialized
countries since 2006. Several studies have been conducted to evaluate the benefit of RV …

Background Rotavirus (RV) infection is the leading cause of diarrhoea‐associated morbidity
and mortality globally among children under 5 years of age. RV vaccination is available, but …

Rotaviruses (RVs) are a major cause of severe diarrhoea in young children. Nicaragua
introduced routine immunization with the pentavalent RV vaccine (RV5) in 2006, which …

OBJECTIVES: Pentavalent rotavirus (RV) vaccine (RV5) was licensed in 2006 and
recommended for routine childhood immunization. A significant decrease in the number of …